The Loire Valley Meeting has been relocated in 2024 in Switzerland and became the Reuss Valley Meeting (RVM).

This event took place on behalf of INPDA on October 19th and 20th organized by NPSuisse and supported by SHG Germany and NPAustralia.

Bellow are some videos of the presentations.

 

SESSIONSPEAKERTOPICLINK ZUM VIDEO
Session I:Fundamental ResearchChairman:Stefan Kolb
Fran Platt The unexpected role of NPC1 in intracellular
pathogen survival

https://vimeo.com/1023917302/43b1e58e32

Emily Eden The effect of NPC1 inhibition on quality control and
repair mechanisms mediated by membrane
contact sites.
https://vimeo.com/1023914841/8f7ed06a04
Lola Ledesma Understanding and Treating Epilepsay in NPC https://vimeo.com/1023928405/5099b825c8
Frank Pfrieger Our research on NPC disease: an overview https://vimeo.com/1023919905/4f8594974f
Andreas Klein Identifying NPC Genetic Modifiers for
Theraputic Intervention and Pharmacogenetics
https://vimeo.com/1023913473/96b157dd3a
Session II:
New Targets and Mode of Actions
Chairman: Heiko Runz
Nick Platt Inflamation in NPC, mechanisms and
therapeutic implications
https://vimeo.com/1023933029/8fb32db2d8
Glen Barber Identification of STING-inducible genes that
facilitate phagocytic activation
 
Isaac Canais Genome Editing and human stem cells to model
and treat lysosomal storage disorders
https://vimeo.com/1023925330/3bae5de13f
Maria Fernandez Role of Plasma Membrane Calcium ATPases in
Niemann-Pick disease type C
 
Ya Hui Hung Message for the brain: mRNA Gene Therapy for
Niemann-Pick Disease Type C
 
Ahad Rahim The development of gene therapy for
Niemann-Pick Type C Disease
https://vimeo.com/1023911291/f25cf615c5
Session III:
Medical
Chairman: Bill Owen
Jordi Gascon Niemann-Pick C and Efavirenz  
Marc Patterson Future NP-C Drugs https://vimeo.com/1023943281/d83192dd2d
Tatiana Bremova-Ertl AAV vectors engineering for CNS-targeted gene therapy https://vimeo.com/1023948683/9e132688ec